Skip to main content
Clinical Trials/NCT02764307
NCT02764307
Completed
Not Applicable

Evaluation of Aerosol Delivery in Different Types of Nebulizers

Chang Gung University0 sites10 target enrollmentOctober 2015
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Chang Gung University
Enrollment
10
Primary Endpoint
Inhaled and exhaled drug concentrations
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Background: Nebulizers design influences efficiency of aerosol delivery. Performance of nebulizers is commonly tested by breathing simulators with static parameters. However, breathing patterns vary in adults.

Objectives: The purpose of this study was to evaluate drug deposition of different types of nebulizers testing with breathing patterns of healthy subjects.

Detailed Description

Material and Methods The study was approved by Chang Gung Memorial Foundation Institutional Review Broad. Ten healthy subjects, aged 20.6±0.5 years, were recruited. Four nebulizers: 1. a constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan); 2. a breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany); 3. a manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan); and 4. a breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) were evaluated.

Registry
clinicaltrials.gov
Start Date
October 2015
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hui-Ling Lin

Assistant professor

Chang Gung University

Eligibility Criteria

Inclusion Criteria

  • Healthy college subjects

Exclusion Criteria

  • Currently smoker
  • History of asthma
  • Drug allergy
  • Pulmonary disease
  • Heart disease
  • Arrythmia
  • Hyperthyroids
  • Diabetes mellitus
  • Lactacidosis
  • Under B-blocker medications

Outcomes

Primary Outcomes

Inhaled and exhaled drug concentrations

Time Frame: Drug deposition was tested Immediately after each nebulization, expected average of 20 minutes

Drug deposited on the collecting filter was analyzed.

Secondary Outcomes

  • Breathing parameters(During each nebulization testing, an expected average of 10 minutes)

Similar Trials